CBD Companies Say Lack of FDA Rules is Hurting Their Businesses

December 3, 2019 09:00:17

The cannabidiol (CBD) industry has seen massive growth in the past few years. Valued at $1.8 billion in 2018, the US CBD market is expected to hit $16.32 billion by 2026, a compound annual growth rate of 27.7%. The genesis can be traced back to the 2018 Hemp Farming Act, legislation that legalized the cultivation of industrial hemp, the plant from which cannabidiol, touted as a miracle drug, is extracted.

Bolstered by this regulation, tons of sellers streamed into the industry, some dealing in hemp farming and others dealing with the CBD end. However, despite the fact that there is obviously an immense market, companies that specialize in CBD-infused products have been having a hard time keeping their profits up. CV Sciences and Charlotte’s Web are among the cannabis companies going through…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.